<table id="_RefID4BDFEA57EB9B43D5B7668AAD278F085C" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2 Dose to body weight range to achieve similar steady-state exposure (AUC ) to unbound oxaprozin in JRA patients relative to 70 kg adult rheumatoid arthritis patients administered oxaprozin 1200 mg QD  
                                                <sub>0-24hr</sub>
<footnote id="_RefIDA306C823217149BCA7B49891E406CF7B">Model-based nomogram derived from unbound oxaprozin steady-state drug plasma concentrations of JRA patients weighing 22.1 kg to 42.7 kg or ≥45.0 kg administered oxaprozin 600 mg or 1200 mg QD for 14 days, respectively.</footnote>
</caption>
<col width="45%"></col>
<col width="49%"></col>
<tbody>
<tr>
<td align="center" stylecode="Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Dose (mg)</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Body Weight Range</content>
</paragraph>
<paragraph>
<content stylecode="bold">(kg)</content>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Lrule Botrule ">
<paragraph>600</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>22 - 31</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Lrule Botrule ">
<paragraph>900</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>32 - 54</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Botrule Lrule ">
<paragraph>1200</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule ">
<paragraph>≥ 55</paragraph>
</td>
</tr>
</tbody>
</table>